A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis
Status:
Terminated
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
Identifying the role of antibiotics in the treatment of subjects with a microbiologically
documented acute exacerbation of chronic bronchitis (AECB) is the purpose of this clinical
trial. The trial has been designed to evaluate the efficacy and safety of faropenem medoxomil
versus placebo in the treatment of subjects with microbiologically documented AECB.